Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SCNX Scienture Holdings, Inc.

Pre-Mkt 06-16 09:22:36 EDT

0.3603

-0.0176

-4.66%

盘前0.3792

+0.0189+5.25%

09:20 EDT

High0.3979	Low0.3491	Vol493.37K
Open0.3930	D1 Closing0.3779	Amplitude12.91%
Mkt Cap14.64M	Tradable Cap12.25M	Total Shares40.63M
T/O182.96K	T/O Rate1.45%	Tradable Shares33.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.3603,"timestamp":1781553600000,"preClose":0.3779,"halted":0,"volume":493374,"hourTrading":{"tag":"盘前","latestPrice":0.3792,"preClose":0.3603,"latestTime":"09:20 EDT","volume":18268,"amount":6935.92189872,"timestamp":1781616047637,"change":0.0189,"changeRate":0.052456,"amplitude":0.112684},"delay":0,"changeRate":-0.046573167504630864,"floatShares":33992500,"shares":40630815,"eps":-1.807909,"marketStatus":"Pre-Mkt","change":-0.0176,"latestTime":"06-16 09:22:36 EDT","open":0.393,"high":0.3979,"low":0.3491,"amount":182960.04139812,"amplitude":0.129135,"askPrice":0.41,"askSize":8,"bidPrice":0.3545,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.807909,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1781616600000},"marketStatusCode":1,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.3603,"preHourTrading":{"tag":"盘前","latestPrice":0.3792,"preClose":0.3603,"latestTime":"09:20 EDT","volume":18268,"amount":6935.92189872,"timestamp":1781616047637,"change":0.0189,"changeRate":0.052456,"amplitude":0.112684},"postHourTrading":{"tag":"盘后","latestPrice":0.36,"preClose":0.3603,"latestTime":"19:58 EDT","volume":7319,"amount":2646.5706,"timestamp":1781567937960,"change":-0.0003,"changeRate":-0.000833,"amplitude":0.063836},"volumeRatio":0.6597184427998125},"requestUrl":"/m/hq/s/SCNX/tweets","defaultTab":"tweets","newsList":[{"id":"2642467683","title":"Scienture says large national health plan adds REZENOPY naloxone spray to formulary","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467683","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642467683?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:05","pubTimestamp":1781006725,"startTime":"0","endTime":"0","summary":"Scienture secured formulary coverage for REZENOPY naloxone 10 mg nasal spray with a large national health plan.Coverage spans commercial insurance, Medicare supplemental plans, extending access to more than 100 million covered lives ahead of a mid-July launch.Prior GPO agreements provide access across more than 5,000 healthcare facilities, covering about 60% of the institutional GPO market.IQVIA data show the U.S. naloxone market at about $144 million in annual sales on 9,800,000 units.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL5jRpv1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710582.SGD","BK4167","IE00B64PRP62.GBP","SG9999014021.USD","IE00BGHQF748.EUR","LU0477156797.USD","BK4121","IE00BN0W2W23.USD","LU1989764748.USD","SG9999014039.USD","NDAQ","IE00BN0W2T93.GBP","LU1791710400.SGD","LU0648001328.SGD","LU2210149790.SGD","LU1989764664.SGD","LU1261432733.SGD","SG9999014013.SGD","LU1201861249.SGD","LU0980610538.SGD","LU0130102774.USD","LU2210150020.SGD","LU0648000940.SGD","LU0477156953.USD","SG9999014005.SGD","BK4530","LU0314104364.USD","LU2095319765.USD","SCNX","LU0130103400.USD","BK4112","LU0130517989.USD","LU0130518102.USD","IE00BKPKM429.USD","LU0198837287.USD","LU1201861165.SGD","IE00BN0W2V16.EUR","IQV","BK4585","IE00B3QW5Z07.USD","LU0882574055.USD","LU0528227936.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642676644","title":"SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2642676644","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642676644?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:05","pubTimestamp":1781006700,"startTime":"0","endTime":"0","summary":"Commercial Launch Planned for Mid-July; 5,000+ Healthcare Facilities Reached Through GPO Agreements, Covering ~60% of Institutional GPO Market U.S. naloxone market totals ~$144 million in annual sales","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3308798/0/en/SCIENTURE-Secures-Formulary-Coverage-for-REZENOPY-with-a-Large-National-Health-Plan-and-Expands-Commercial-Team.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","BK4120","BK4167","NHLD","TISI","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640948553","title":"Scienture wins US patent for REZENOPY naloxone nasal spray, protection through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2640948553","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640948553?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:09","pubTimestamp":1780402179,"startTime":"0","endTime":"0","summary":"Scienture Holdings received a US patent covering REZENOPY naloxone HCl nasal spray 10 mg, effective May 12, 2026; expires Feb. 5, 2041.Patent adds IP protection ahead of a planned mid-July US commercial launch of the 10 mg product, the highest FDA-approved naloxone dose per spray.Exclusive US commercialization rights secured under a March 2025 agreement with Summit Biosciences, which will manufacture and supply the product.IQVIA data show the US naloxone market at about USD 141 million in annual sales on 9,400,000 units as of January 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL3mMznt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989764664.SGD","SG9999014039.USD","BK4121","LU0130103400.USD","SG9999014005.SGD","LU0130518102.USD","NDAQ","LU0648000940.SGD","IE00BKPKM429.USD","LU0477156953.USD","LU2210149790.SGD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","IQV","LU0130517989.USD","BK4588","BK4585","LU0882574055.USD","LU1791710582.SGD","LU1989764748.USD","LU0477156797.USD","SCNX","SG9999014013.SGD","BK4167","BK4530","BK4112","IE00BN0W2V16.EUR","LU0130102774.USD","IE00BN0W2T93.GBP","LU0198837287.USD","LU1201861165.SGD","SG9999014021.USD","LU1791710400.SGD","LU0528227936.USD","LU1261432733.SGD","LU0648001328.SGD","LU2210150020.SGD","LU2095319765.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU1201861249.SGD","LU0980610538.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640094883","title":"Scienture Receives U.S. Patent Covering Rezenopy™ (Naloxone Hcl) Nasal Spray 10 Mg, Strengthening Intellectual Property Protection Through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2640094883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640094883?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:05","pubTimestamp":1780401911,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A0MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943330","title":"SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943330","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640943330?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:05","pubTimestamp":1780401900,"startTime":"0","endTime":"0","summary":"U.S. Naloxone Market: ~$141 million in annual sales and 9.4 million units annually COMMACK, NY, June  02, 2026  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for exist","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3305134/0/en/SCIENTURE-Receives-U-S-Patent-Covering-REZENOPY-Naloxone-HCl-Nasal-Spray-10-mg-Strengthening-Intellectual-Property-Protection-Through-2041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639770246","title":"BRIEF-Scienture - Eric Sherb Resigns As CFO Effective May 26, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2639770246","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639770246?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:06","pubTimestamp":1780088798,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture - Eric Sherb Resigns As CFO Effective May 26, 2026 May 29  - Scienture Holdings Inc SCNX.O:SCIENTURE - ERIC SHERB RESIGNS AS CFO EFFECTIVE MAY 26, 2026 - SEC FILINGSCIENTURE - APPOINTS NARASIMHAN MANI AS INTERIM CFO EFFECTIVE MAY 26, 2026 - SEC FILINGFurther company coverage: SCNX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4261DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639667777","title":"Scienture - Appoints Narasimhan Mani as Interim CFO Effective May 26, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2639667777","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639667777?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:02","pubTimestamp":1780088542,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4261DK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639677717","title":"Scienture names Narasimhan Mani interim CFO after Eric Sherb resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2639677717","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639677717?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:01","pubTimestamp":1780088505,"startTime":"0","endTime":"0","summary":"Scienture Holdings named Dr. Narasimhan Mani interim CFO effective May 26, 2026.He replaces Eric Sherb, who resigned as CFO May 26 for personal reasons.Mani has been a director, co-CEO, and president since May 2025, overseeing operations including financial planning and reporting.He previously led Kesin Pharma as CEO, ran Xiromed, and held a strategy and business development role at Amneal Pharmaceuticals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL2bsp41:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX","BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636751920","title":"Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady","url":"https://stock-news.laohu8.com/highlight/detail?id=2636751920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636751920?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:47","pubTimestamp":1779108439,"startTime":"0","endTime":"0","summary":"Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steadyOverviewUS specialty pharma firm's Q1 revenue rose 449% yr/yr on increased Arbli product ordersGross margin expanded to 95.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nL1N41V0HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636075580","title":"Scienture Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2636075580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636075580?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:38","pubTimestamp":1779107881,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nTUA5TQLJR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636907553","title":"Scienture Holdings, Inc Q1 Gross Profit USD 54 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2636907553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636907553?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:38","pubTimestamp":1779107880,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nPLX8482DA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636075538","title":"Scienture Holdings, Inc Q1 Operating Expenses USD 3.56 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2636075538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636075538?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:38","pubTimestamp":1779107880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nPLX8482DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636407551","title":"SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2636407551","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636407551?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:38","pubTimestamp":1779107880,"startTime":"0","endTime":"0","summary":"COMMACK, NY, May  18, 2026  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding company for existing and planned pharmaceutical operating companies focused on providin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3296641/0/en/SCIENTURE-Reports-First-Quarter-2026-Financial-Results-and-Business-Update-Highlighted-by-Significant-Revenue-Growth-and-Gross-Margin-Expansion.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ARB","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635053097","title":"Scienture Holdings Q1 EPS $(0.08) Beats $(0.22) Estimate, Sales $56.325K Up From $10.258K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635053097","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635053097?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:12","pubTimestamp":1778883129,"startTime":"0","endTime":"0","summary":"Scienture Holdings (NASDAQ:SCNX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.22) by 63.64 percent. This is a 75.76 percent increase over losses of $(0.33) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620165/scienture-holdings-q1-eps-0-08-beats-0-22-estimate-sales-56-325k-up-from-10-258k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Scienture Holdings Q1 EPS $(0.08) Beats $(0.22) Estimate, Sales $56.325K Up From $10.258K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635794030","title":"Scienture net loss widens 11% to $3.4 million in Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2635794030","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635794030?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:41","pubTimestamp":1778877663,"startTime":"0","endTime":"0","summary":"Scienture Holdings posted a net loss of $3.4 million for quarter ended March 31, 2026, widening 11% year over year.Revenue climbed to $56,325, up 449% from year earlier, as wholesale distribution sales of SCN-102  continued to ramp following its commercial launch.Research and development expense rose to $793,984, up 38%, driven by higher contract research organization costs tied to advancing pipeline candidates.Cash fell to $3.54 million at March 31, 2026, down 47% from year-end 2025, while net cash used in operating activities was $2.92 million, down 1% year over year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Ga","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL3Mm8ZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635030289","title":"Scienture Holdings Inc  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2635030289","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635030289?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:38","pubTimestamp":1778877488,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc  expected to post a loss of22cents a share - Earnings Preview Scienture Holdings Inc SCNX.OQ SCNX.O is expected to  report resultson May 18 (estimated) for the period ending Mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S23V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634965462","title":"Scienture Holdings Inc  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634965462","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634965462?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:36","pubTimestamp":1778272567,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc  expected to post a loss of22cents a share - Earnings Preview Scienture Holdings Inc SCNX.OQ SCNX.O is expected to  report resultson May 11 (estimated) for the period ending Mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144765","title":"BRIEF-Scienture Secures $11.0 Million In Non-Dilutive Debt Financing To Accelerate Growth Of Approved Product Portfolio And Advancement Of Research And Development Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144765","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144765?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:15","pubTimestamp":1778156137,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Secures $11.0 Million In Non-Dilutive Debt Financing To Accelerate Growth Of Approved Product Portfolio And Advancement Of Research And Development PipelineMay 7 (Reuters) - Scienture ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA7DRZXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633514428","title":"Scienture secures $11 million non-dilutive debt financing from institutional investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2633514428","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633514428?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:13","pubTimestamp":1778156021,"startTime":"0","endTime":"0","summary":"Scienture secured $11 million in non-dilutive debt financing via a note purchase agreement with an institutional investor.Financing included two non-convertible promissory notes: $8.42 million promissory note, $3 million secured promissory note.Net proceeds of about $11 million earmarked for commercialization of Arbli and REZENOPY, with additional funding for clinical development of pipeline programs.Transaction disclosed in a Form 8-K filed May 1, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLbtCHGR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014021.USD","IE00BKPKM429.USD","SG9999014005.SGD","BK4112","BK4588","IE00B64PRP62.GBP","SCNX","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU0314104364.USD","NDAQ","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","LU2095319765.USD","BK4167","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144476","title":"Scienture Holdings - Enters Definitive Agreement With Summit Biosciences for Exclusive U.S. Rights to Commercialize Rezenopy","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144476","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144476?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:05","pubTimestamp":1778155500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA7DRZXY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientureholdings.com","stockEarnings":[{"period":"1week","weight":0.0236},{"period":"1month","weight":-0.106},{"period":"3month","weight":-0.2448},{"period":"6month","weight":-0.2794},{"period":"1year","weight":-0.6631},{"period":"ytd","weight":-0.2935}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.1253},{"period":"6month","weight":0.1243},{"period":"1year","weight":0.2644},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.119636},{"month":2,"riseRate":0.333333,"avgChangeRate":0.150517},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.073293},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.066727},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.09045},{"month":6,"riseRate":0.857143,"avgChangeRate":0.465122},{"month":7,"riseRate":0.666667,"avgChangeRate":0.096061},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.16799},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.047954},{"month":10,"riseRate":0,"avgChangeRate":-0.160548},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067192},{"month":12,"riseRate":0,"avgChangeRate":-0.185859}],"exchange":"NASDAQ","name":"Scienture Holdings, Inc.","nameEN":"Scienture Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Scienture Holdings, Inc.(SCNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Scienture Holdings, Inc.,SCNX,Scienture Holdings, Inc.股票,Scienture Holdings, Inc.股票老虎,Scienture Holdings, Inc.股票老虎国际,Scienture Holdings, Inc.行情,Scienture Holdings, Inc.股票行情,Scienture Holdings, Inc.股价,Scienture Holdings, Inc.股市,Scienture Holdings, Inc.股票价格,Scienture Holdings, Inc.股票交易,Scienture Holdings, Inc.股票购买,Scienture Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Scienture Holdings, Inc.(SCNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}